ROSEN, A Longstanding Law Firm, Urges Gritstone bio, Inc. Investors to Seek Legal Counsel Ahead of Deadline in Class Action Lawsuit - GRTS

NEW YORK, June 20, 2024 (GLOBE NEWSWIRE) -- Investors who have purchased shares of Gritstone bio, Inc. GRTS, a clinical-stage biotechnology company, are being called upon by Rosen Law Firm, renowned for representing shareholders, to seek legal advice promptly. This notice targets investors who acquired GRTS stock during the period from March 9, 2023, to February 29, 2024, warning them of an upcoming deadline of August 6, 2024, to potentially serve as a lead plaintiff in a class-action lawsuit suffering losses from GRTS securities.

About Gritstone bio, Inc.

Gritstone bio, Inc., with its headquarters in Emeryville, California, operates as a trailblazing biotech entity specializing in the advancement of cancer immunotherapies and vaccines for infectious diseases. The company's focus is to develop targeted treatments for numerous cancers and persistent global health threats by leveraging its technological and scientific expertise.

Details of the Securities Class Action

The lawsuit alleges that stakeholders of GRTS securities were potentially misled about material information that impacted their investment decisions. Rosen Law Firm endeavors to ensure the integrity of the investment community by assisting investors in exercising their legal rights. Affected parties are urged to seek out experienced counsel without delay, ensuring they are represented before the court if they have been financially impacted by their investments in GRTS.

Why Legal Representation is Essential

Choosing to participate in a securities class action can potentially recoup considerable losses for investors. A lead plaintiff is a representative party acting on behalf of other class members to direct the litigation process. Rosen Law Firm is extending a reminder to GRTS investors that the cut-off date to apply to become a putative lead plaintiff is rapidly approaching. Those who have significant losses and wish to contribute to the lawsuit's direction should immediately consult with legal experts to safeguard their interests.

Investors, Legal, Deadline